# pRESET for Occlusive Stroke Treatment

Study · id `cardio:ct-nct03994822` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03994822](<https://clinicaltrials.gov/study/NCT03994822>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03994822

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 340 participants.

## Technical summary

Registry record NCT03994822. Randomized; single masking; primary purpose treatment. Start 2019-10-04 (actual); primary completion 2022-05-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 340 participants (enrolled count; ClinicalTrials.gov record NCT03994822, source copy `cardio:ctgov-nct03994822-2023-04-21`, retrieved 2026-10-26)
- Started: 2019-10-04 (actual) (ClinicalTrials.gov record NCT03994822, source copy `cardio:ctgov-nct03994822-2023-04-21`, retrieved 2026-10-26)
- Primary completion: 2022-05-12 (actual) (ClinicalTrials.gov record NCT03994822, source copy `cardio:ctgov-nct03994822-2023-04-21`, retrieved 2026-10-26)
- Completion: 2022-05-12 (actual) (ClinicalTrials.gov record NCT03994822, source copy `cardio:ctgov-nct03994822-2023-04-21`, retrieved 2026-10-26)
- Countries: United States; Germany (ClinicalTrials.gov record NCT03994822, source copy `cardio:ctgov-nct03994822-2023-04-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03994822-2023-04-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: pRESET for Occlusive Stroke Treatment
- Acronym: PROST
- Condition: Brain Diseases
- Condition: Cardiovascular Diseases
- Condition: Central Nervous System Diseases
- Condition: Cerebrovascular Disorders
- Condition: Ischemia
- Condition: Nervous System Diseases
- Condition: Pathologic Processes
- Condition: Stroke, Ischemic
- Condition: Stroke, Acute
- Condition: Vascular Diseases
- Intervention (Device): Mechanical Thrombectomy using the pRESET Thrombectomy device
- Intervention (Device): Mechanical Thrombectomy using the Solitaire Revascularization Device
- Lead sponsor: phenox Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 4b092047b83a5b8e089236c4d3724d78930cb49420f5948f2f09cb1f649ad9e0
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
